Fred B. Craves, Director at PONIARD PHARMACEUTICALS, INC. (PARD), bought 5,000 shares at $2.12 ($11K) on 2009-03-27, disclosed to the SEC on 2009-03-30.
Open-market purchase of $11k PARD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.12 | 400 | $848 | 7.9% |
| 2 | $2.13 | 100 | $213 | 2.0% |
| 3 | $2.14 | 1,200 | $3K | 23.9% |
| 4 | $2.15 | 3,300 | $7K | 66.2% |
| Total | $2.14 avg | 5,000 | $11K | 100% |
| Filing → |
| MDGL | SELL | 2024-11-27 | $1.2M | — | Filing → |
| MDGL | SELL | 2024-05-16 | $9.3M | — | Filing → |
| MDGL | SELL | 2020-08-19 | $5.2M | — | Filing → |